Gamma-delta T cell ligands (γδTCL) (γδTCL)

Gamma-delta (γδ) T cell ligands are a heterogeneous group of molecules expressed on the surface of tumor or stressed cells that trigger the activation of γδ T cells (Vantourout & Hayday, 2013). Unlike conventional αβ T cells, γδ T cells recognize these ligands in an MHC-independent manner, allowing for a rapid, innate-like response to cellular transformation or infection (Rigau et al., 2020). Key ligands include the butyrophilin family (notably BTN3A1 and BTN2A1), which are essential for the sensing of intracellular phosphoantigens like isopentenyl pyrophosphate (IPP) by Vγ9Vδ2 T cells (Karunakaran et al., 2014). Other important ligands include MHC class I-related molecules such as MICA and MICB, which interact with the NKG2D costimulatory receptor to enhance cytotoxicity (Bauer et al., 1999). In oncology, these ligands serve as critical 'red flags' that allow γδ T cells to selectively identify and lyse malignant cells while sparing healthy tissue (Sebestyen et al., 2020). Therapeutic strategies targeting this axis include bispecific γδ T cell engagers (Gammabodies), monoclonal antibodies that stabilize butyrophilin complexes (e.g., ICT01), and small molecules like aminobisphosphonates that increase endogenous ligand levels (ImCheck Therapeutics, 2023; Dieli et al., 2003). However, the potential for off-target effects on healthy cells undergoing physiological stress remains a significant therapeutic challenge.

Other names

Stress-induced ligandsγδ TCR ligandsButyrophilinsMICA/BULBPsPhosphoantigen-presenting moleculesNon-peptide antigens

Activation of γδ T cells through ligand stabilization, bispecific engagement of the γδ TCR and tumor antigens, or indirect induction of intracellular phosphoantigen accumulation via metabolic pathway inhibition.